异动解读 | 莫德纳获59亿美元政府资金研发禽流感疫苗,盘后大涨5.11%

异动解读
18 Jan

莫德纳公司(MRNA.O)今日盘后大涨5.11%,引起了市场的广泛关注。

据报道,美国政府已向莫德纳公司拨款5.9亿美元,用于推进其mRNA禽流感疫苗的后期开发,因为美国正加倍努力应对严重的人类感染。这笔资金将用于加速开发基于mRNA的大流行性流感疫苗。

作为一家领先的mRNA疫苗公司,莫德纳公司持续获得政府资助,进一步扩大其在疫苗研发领域的布局,增强了市场对其长期增长潜力的信心,推动股价在盘后大幅上涨。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10